Sequenced Here, Stored Somewhere Else

Africa expanded pathogen genomic sequencing capacity from 7 to 46 countries between 2019 and 2024, but the data infrastructure required to retain, govern, and act on that data did not follow. Existing international archiving protocols — GISAID, INSDC — were designed without African governance representation and structurally prioritize offshore storage. Africa has no continent-controlled pathogen genomic repository with enforceable data sovereignty provisions. The consequence is that African institutions generate data, contribute it to systems they do not govern, and receive no guaranteed reciprocal access or policy standing when outbreaks escalate.

The Omicron variant was first sequenced and reported by South African scientists in November 2021; within days, over 70 countries imposed travel bans on southern African nations, directly punishing the states that shared data fastest. This created a documented disincentive for transparent reporting that will affect future outbreak response. Sequencing capacity remains highly concentrated: 70% of Africa's sequencers are in 5 countries, meaning even the existing offshore-governed data pipeline is geographically unrepresentative of the continent's actual disease burden.

GISAID became the de facto global repository for SARS-CoV-2 sequences, but its governance structure has no African institutional representation, and its terms of use limit what depositing labs can do with their own submissions. The Nagoya Protocol provides a legal framework for biological resource sovereignty, but it was not designed for real-time outbreak pathogen data and is effectively unenforceable at sequencing timescales. Individual African countries have begun developing national bioinformatics platforms, but fragmented national systems produce fragmented datasets that cannot support continent-level surveillance. Africa CDC launched AGARI (African Genomic Archive and Research Infrastructure) in November 2025, which is a meaningful structural step, but the platform's governance framework — who controls access decisions, who sets sharing terms, how benefit-sharing is enforced — remains undeveloped at launch.

A technically functional African-controlled repository already exists in embryonic form through AGARI; what is missing is the governance architecture that makes control meaningful. Drafting enforceable data-sharing terms, benefit-sharing provisions, and access-tier rules — and getting AU member states to ratify them — would convert AGARI from a storage system into a sovereignty instrument. Parallel work is needed on bioinformatics workforce distribution across currently underrepresented countries to ensure the repository's inputs are geographically representative.

A design team could map the governance gap explicitly: what decisions does GISAID's current structure make that African depositors cannot override, and what provisions would an African-designed equivalent need to include? A policy or legal team could draft a model data-sharing agreement that operationalizes benefit-sharing in the outbreak-genomics context. A systems team could model the sequencing infrastructure distribution problem — what minimum national capacity, in what countries, would make AGARI's inputs epidemiologically representative?